Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Predictive Oncology Inc. POAI

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Eyes Expansion of AI-Driven Clinical Models

Predictive Oncology (NASDAQ: POAI) has set sights on other cancers after completing its data generation milestones in a collaborative study with UPMC-Magee Women Hospital. With the comprehensive genomic and transcriptomic sequencing of patient samples now complete, thanks to the study, … Continue reading

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Taps Its Chairman to be CEO

Current POAI Chairman J. Melville (“Mel”) Engle has been appointed to CEO positionEngle has held executive positions throughout his career at leading pharma and medical device companies, including Dey L.P. (a subsidiary of Merck KGaA), Allergan, Anika Therapeutics and ThermogenesisDuring … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Leverages Multi-Omic Approach to New Drug Discovery

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven company focused on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery. While the pharmaceutical industry has historically invested heavily in genomics and big data, hoping to better understand … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systemsHelomics model evaluates multiple measurements in powerful multi-omics approach to cancer researchKnowledge encapsulated by Helomics AI is “gold dust,” says chief … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) Appoints Board Chair as New CEO

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announce the appointment of a new CEO: J. Melville (“Mel”) Engle. Engle is currently serving as chairman of the board and … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Working on Gen 3 Fluid-to-Drain Liquid Waste Management System for Hospitals

Fluid management systems, accessories market forecast at 13.6% CAGR to $16.1 billion by 2025Skyline Medical’s STREAMWAY(R) System disrupts today’s standard of manually moving waste fluid for disposalSTREAMWAY Systems eliminates waste transport, disposal costs, equipment relocation and risk of exposure to … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) Releases FY 2020 Financial Results, Business Highlights

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has reported business highlights and  financial results for the year ended Dec. 31, 2020. Highlights discussed in the report include the … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Hits Milestone in AI Platform Development for Ovarian Cancer

Cancer screenings, treatments declined during COVID-19 pandemic, highlighting need for personalized therapies to improve outcomesComprehensive genomic, transcriptomic sequencing of patient samples complete, patient outcome data obtained from UPMC-MageeProject is template for future partnerships with other healthcare institutions to expand POAI’s … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Development of Newly Designed System for Direct-to-Drain Fluid Waste Management

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its Skyline Medical Division is renewing the development of a new Generation 3 STREAMWAY(R) System for direct-to-drain fluid … Continue reading

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering.Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively.Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment